Le Lézard
Classified in: Health

James Feldkamp to Release New Blog on Terrorism


LOS ANGELES, July 19, 2018 /PRNewswire-PRWeb/ -- Many people around the world genuinely fear terrorism, but Counterterrorism expert James Feldkamp is attempting to change this through the release of a brand-new terrorism blog to make its debut in September.

According to Feldkamp, today's world is an extremely stressful place, but most of the time, this fear stems from a fear of the unknown. Thus, the aim of Feldkamp's new blog is to eliminate people's fear of terrorism by providing an introduction to it along with a history of terrorism. Through the blog, readers can also learn more about the effect that terrorism has on world events today. For instance, noteworthy terrorism-related attacks last year in England alone included a Manchester Arena bombing and a London Bridge attack.

Feldkamp's blog recently underwent a successful closed beta testing run. As a result, an open beta testing phase will take place starting on Aug. 1, with version 1.0 of the website being ready by September.

Feldkamp is a lead consultant for a company called Intelligence & Counterterrorism at Complete Threat Preparedness. The company comprises professionals in the areas of military special operations and intelligence, construction, survival, self-defense, public safety, and emergency management. As part of the organization, Feldkamp trains and consults with both organizations and individuals in the private and public sectors on protection against manmade and natural hazards, safety, and security.

Feldkamp has more than two decades of experience in foreign policy and international security initiatives, serving both the military and the federal government. He has used his expertise to boost maritime security and domain awareness as well as enhance inter-agency communications related to global matters.

Jim Feldkamp has additionally taught university courses related to transnational crimes, counterterrorism, terrorism, and international security. In addition, he has given presentations on terrorism and global security at more than 25 major symposia and conferences across the globe.

SOURCE James Feldkamp


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: